Steminent Biotherapeutics Inc. (TPEX:7729)
82.70
+4.40 (5.62%)
Apr 28, 2026, 2:00 PM CST
258.79% (1Y)
| Market Cap | 5.51B |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -174.04M |
| Shares Out | 66.63M |
| EPS (ttm) | -2.95 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 523,267 |
| Average Volume | 398,343 |
| Open | 78.90 |
| Previous Close | 78.30 |
| Day's Range | 75.10 - 83.10 |
| 52-Week Range | 19.55 - 95.60 |
| Beta | 0.70 |
| RSI | 53.49 |
| Earnings Date | Apr 29, 2026 |